Microsphere analysis services, POP 23 september 2019 - 22 september 2020, plus 4 one-year option periods at tamc, HI
Ended Purchase Order Awarded Last action
- Contract number
- W81K0219P0216
- Awardee
-
Stason Pharmaceuticals, Inc. UEI T9M7KCTSZNL3
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $52,992
Award facts
- Opportunity
-
- Microsphere Analysis Services for Tripler Army Medical Center, HI Pre-Solicitation · W81K0219Q0232 · Posted Aug 8, 2019
- Microsphere Analysis Services at Tripler Army Medical Center, Hawaii Limited / Sole Source Justification · Posted Sep 19, 2019
- Microsphere Analysis Services at Tripler Army Medical Center, Hawaii Award Notice · Posted Sep 19, 2019
- Microsphere Analysis Services at Tripler Army Medical Center, Hawaii Pre-Solicitation · Posted Sep 9, 2019
- Microsphere Analysis Services at Tripler Army Medical Center, Hawaii Pre-Solicitation · Posted Sep 4, 2019
- Contract value 19% obligated
-
- $52,992.00 Current, with exercised options
- $277,070.40 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Irvine, CA 92618, USA
Award details come from SAM.gov/FPDS.
About this award
The Department of the Army Medical Command awarded a firm-fixed-price purchase order to Stason Pharmaceuticals, Inc., a minority-owned, for-profit business, to provide microsphere analysis services at Tripler Army Medical Center (TAMC) in Hawaii. The base period of performance is from September 23, 2019 to September 22, 2020, with four 1-year option periods, for a potential total value of $277,070.40. The services include providing assay measurements of colored microspheres from blood and tissue samples to determine regional microcirculatory blood flow. The contract has no set-aside designation. The award was based on a sources sought notice posted on August 9, 2019, which provided the detailed requirements for the technical personnel and experience needed to perform the services.
Quick answers
Who was awarded contract W81K0219P0216?
W81K0219P0216 was awarded to Stason Pharmaceuticals, Inc. by Medical Command (Department of the Army) on September 23, 2019.
How much is contract W81K0219P0216 worth?
The government has obligated $52,992 on W81K0219P0216. Its potential value, with all options, is $277,070.
Was contract W81K0219P0216 competed?
The extent of competition for W81K0219P0216 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award